Cargando…
LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection
Sustained elimination of leprosy as a global health concern likely requires a vaccine. The current standard, BCG, confers only partial protection and precipitates paucibacillary (PB) disease in some instances. When injected into mice with the T helper 1 (Th1)-biasing adjuvant formulation Glucopyrano...
Autores principales: | Duthie, Malcolm S., Pena, Maria T., Ebenezer, Gigi J., Gillis, Thomas P., Sharma, Rahul, Cunningham, Kelly, Polydefkis, Michael, Maeda, Yumi, Makino, Masahiko, Truman, Richard W., Reed, Steven G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871809/ https://www.ncbi.nlm.nih.gov/pubmed/29619252 http://dx.doi.org/10.1038/s41541-018-0050-z |
Ejemplares similares
-
Author Correction: LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection
por: Duthie, Malcolm S., et al.
Publicado: (2018) -
An in vitro model of Mycobacterium leprae induced granuloma formation
por: Wang, Hongsheng, et al.
Publicado: (2013) -
Nitazoxanide is active against Mycobacterium leprae
por: Bailey, Mai Ann, et al.
Publicado: (2017) -
A Lipopeptide Facilitate Induction of Mycobacterium leprae Killing in Host Cells
por: Maeda, Yumi, et al.
Publicado: (2011) -
Profiling of Intracellular Metabolites: An Approach to Understanding the Characteristic Physiology of Mycobacterium leprae
por: Miyamoto, Yuji, et al.
Publicado: (2016)